Boston Scientific Corp.

Boston Scientific has issued a recall of certain AXIOS stents and electrocautery-enhanced delivery systems due to deployment and expansion difficulties. As of December 23, the company reported 167 serious injuries and 3 deaths associated with the issue. The FDA is actively reviewing the potentially high-risk device issue. The complications occur ...

The global synthetic absorbable sutures market is valued at USD 2.51 billion in 2025 and is projected to reach USD 4.36 billion by 2033, growing at a CAGR of 7.19%. Growth is driven by rising surgical volumes, increasing adoption of minimally invasive procedures, and advancements in polymer technology. However, higher costs compared to convention...

Investor rights law firm Halper Sadeh LLC is investigating three companies for potential securities law violations and fiduciary duty breaches related to major transactions: Penumbra's $374 per share sale to Boston Scientific, Calavo's acquisition by Mission Produce for $14.85 cash plus stock, and Mission Produce's merger with Calavo. The firm is...

This week's M&A activity spans major acquisitions and bankruptcies. Boston Scientific agreed to acquire Penumbra for $14.6 billion, expanding its neurovascular presence. Devon Energy and Coterra Energy are in merger discussions to create a major shale producer. Paramount Skydance's lawsuit against Warner Bros. Discovery was rejected by a Delaware...

A comprehensive market analysis report on atherectomy devices covering 39 countries with forecasts through 2036. The market is driven by the shift toward minimally-invasive techniques for treating coronary and peripheral artery diseases, replacing traditional bypass surgery. The report provides detailed market segmentation, intervention volumes, ...